List of Tables
    Table 1. Oral Antidiabetic Agents Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Oral Antidiabetic Agents Market Trends
    Table 3. Oral Antidiabetic Agents Market Drivers
    Table 4. Oral Antidiabetic Agents Market Challenges
    Table 5. Oral Antidiabetic Agents Market Restraints
    Table 6. Global Oral Antidiabetic Agents Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Oral Antidiabetic Agents Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Oral Antidiabetic Agents Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Oral Antidiabetic Agents Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Oral Antidiabetic Agents Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Oral Antidiabetic Agents Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Oral Antidiabetic Agents Revenue Share by Player, 2017-2022
    Table 13. Global Oral Antidiabetic Agents Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Oral Antidiabetic Agents by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Antidiabetic Agents as of 2021)
    Table 15. Top Players of Oral Antidiabetic Agents in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Oral Antidiabetic Agents Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Oral Antidiabetic Agents Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Oral Antidiabetic Agents Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Oral Antidiabetic Agents Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Oral Antidiabetic Agents Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Oral Antidiabetic Agents Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Oral Antidiabetic Agents Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Oral Antidiabetic Agents Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Oral Antidiabetic Agents Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Oral Antidiabetic Agents Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Oral Antidiabetic Agents Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Oral Antidiabetic Agents Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Oral Antidiabetic Agents Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Novo Nordisk Company Details
    Table 31. Novo Nordisk Business Overview
    Table 32. Novo Nordisk Oral Antidiabetic Agents Product
    Table 33. Novo Nordisk Revenue in Oral Antidiabetic Agents Business (2017-2022) & (US$ Million)
    Table 34. Novo Nordisk Recent Development
    Table 35. Eli Lilly Company Details
    Table 36. Eli Lilly Business Overview
    Table 37. Eli Lilly Oral Antidiabetic Agents Product
    Table 38. Eli Lilly Revenue in Oral Antidiabetic Agents Business (2017-2022) & (US$ Million)
    Table 39. Eli Lilly Recent Development
    Table 40. Sanofi Company Details
    Table 41. Sanofi Business Overview
    Table 42. Sanofi Oral Antidiabetic Agents Product
    Table 43. Sanofi Revenue in Oral Antidiabetic Agents Business (2017-2022) & (US$ Million)
    Table 44. Sanofi Recent Development
    Table 45. Roche Company Details
    Table 46. Roche Business Overview
    Table 47. Roche Oral Antidiabetic Agents Product
    Table 48. Roche Revenue in Oral Antidiabetic Agents Business (2017-2022) & (US$ Million)
    Table 49. Roche Recent Development
    Table 50. Teva Company Details
    Table 51. Teva Business Overview
    Table 52. Teva Oral Antidiabetic Agents Product
    Table 53. Teva Revenue in Oral Antidiabetic Agents Business (2017-2022) & (US$ Million)
    Table 54. Teva Recent Development
    Table 55. AstraZeneca Company Details
    Table 56. AstraZeneca Business Overview
    Table 57. AstraZeneca Oral Antidiabetic Agents Product
    Table 58. AstraZeneca Revenue in Oral Antidiabetic Agents Business (2017-2022) & (US$ Million)
    Table 59. AstraZeneca Recent Development
    Table 60. Wockhardt UK Company Details
    Table 61. Wockhardt UK Business Overview
    Table 62. Wockhardt UK Oral Antidiabetic Agents Product
    Table 63. Wockhardt UK Revenue in Oral Antidiabetic Agents Business (2017-2022) & (US$ Million)
    Table 64. Wockhardt UK Recent Development
    Table 65. Merck Company Details
    Table 66. Merck Business Overview
    Table 67. Merck Oral Antidiabetic Agents Product
    Table 68. Merck Revenue in Oral Antidiabetic Agents Business (2017-2022) & (US$ Million)
    Table 69. Merck Recent Development
    Table 70. Pfizer Company Details
    Table 71. Pfizer Business Overview
    Table 72. Pfizer Oral Antidiabetic Agents Product
    Table 73. Pfizer Revenue in Oral Antidiabetic Agents Business (2017-2022) & (US$ Million)
    Table 74. Pfizer Recent Development
    Table 75. Cipla Company Details
    Table 76. Cipla Business Overview
    Table 77. Cipla Oral Antidiabetic Agents Product
    Table 78. Cipla Revenue in Oral Antidiabetic Agents Business (2017-2022) & (US$ Million)
    Table 79. Cipla Recent Development
    Table 80. Research Programs/Design for This Report
    Table 81. Key Data Information from Secondary Sources
    Table 82. Key Data Information from Primary Sources
List of Figures
    Figure 1. Oral Antidiabetic Agents Product Picture
    Figure 2. Global Oral Antidiabetic Agents Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Oral Antidiabetic Agents Market Size 2017-2028 (US$ Million)
    Figure 4. United States Oral Antidiabetic Agents Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Oral Antidiabetic Agents Market Size 2017-2028 (US$ Million)
    Figure 6. United States Oral Antidiabetic Agents Market Share in Global 2017-2028
    Figure 7. Oral Antidiabetic Agents Report Years Considered
    Figure 8. Product Picture of Sulfonylureas
    Figure 9. Product Picture of Meglitinides
    Figure 10. Product Picture of Biguanides
    Figure 11. Product Picture of Thiazolidinediones
    Figure 12. Product Picture of Alpha-glucosidase Inhibitors
    Figure 13. Global Oral Antidiabetic Agents Market Share by Type in 2022 & 2028
    Figure 14. Global Oral Antidiabetic Agents Market Size by Type (2017-2028) & (US$ Million)
    Figure 15. Global Oral Antidiabetic Agents Market Share by Type (2017-2028)
    Figure 16. United States Oral Antidiabetic Agents Market Share by Type in 2022 & 2028
    Figure 17. United States Oral Antidiabetic Agents Market Size by Type (2017-2028) & (US$ Million)
    Figure 18. United States Oral Antidiabetic Agents Market Share by Type (2017-2028)
    Figure 19. Product Picture of Home Use
    Figure 20. Product Picture of Medical Institutions
    Figure 21. Product Picture of Others
    Figure 22. Global Oral Antidiabetic Agents Market Share by Application in 2022 & 2028
    Figure 23. Global Oral Antidiabetic Agents Market Size by Application (2017-2028) & (US$ Million)
    Figure 24. Global Oral Antidiabetic Agents Market Share by Application (2017-2028)
    Figure 25. United States Oral Antidiabetic Agents Market Share by Application in 2022 & 2028
    Figure 26. United States Oral Antidiabetic Agents Market Size by Application (2017-2028) & (US$ Million)
    Figure 27. United States Oral Antidiabetic Agents Market Share by Application (2017-2028)
    Figure 28. North America Oral Antidiabetic Agents Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 29. U.S. Oral Antidiabetic Agents Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 30. Canada Oral Antidiabetic Agents Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 31. Europe Oral Antidiabetic Agents Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 32. Germany Oral Antidiabetic Agents Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. France Oral Antidiabetic Agents Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. U.K. Oral Antidiabetic Agents Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 35. Italy Oral Antidiabetic Agents Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. Russia Oral Antidiabetic Agents Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. Asia-Pacific Oral Antidiabetic Agents Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 38. China Oral Antidiabetic Agents Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. Japan Oral Antidiabetic Agents Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. South Korea Oral Antidiabetic Agents Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. India Oral Antidiabetic Agents Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Australia Oral Antidiabetic Agents Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Taiwan Oral Antidiabetic Agents Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Indonesia Oral Antidiabetic Agents Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Thailand Oral Antidiabetic Agents Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Malaysia Oral Antidiabetic Agents Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Philippines Oral Antidiabetic Agents Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Latin America Oral Antidiabetic Agents Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 49. Mexico Oral Antidiabetic Agents Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Brazil Oral Antidiabetic Agents Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Argentina Oral Antidiabetic Agents Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Middle East & Africa Oral Antidiabetic Agents Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 53. Turkey Oral Antidiabetic Agents Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Saudi Arabia Oral Antidiabetic Agents Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 55. U.A.E Oral Antidiabetic Agents Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 56. Novo Nordisk Revenue Growth Rate in Oral Antidiabetic Agents Business (2017-2022)
    Figure 57. Eli Lilly Revenue Growth Rate in Oral Antidiabetic Agents Business (2017-2022)
    Figure 58. Sanofi Revenue Growth Rate in Oral Antidiabetic Agents Business (2017-2022)
    Figure 59. Roche Revenue Growth Rate in Oral Antidiabetic Agents Business (2017-2022)
    Figure 60. Teva Revenue Growth Rate in Oral Antidiabetic Agents Business (2017-2022)
    Figure 61. AstraZeneca Revenue Growth Rate in Oral Antidiabetic Agents Business (2017-2022)
    Figure 62. Wockhardt UK Revenue Growth Rate in Oral Antidiabetic Agents Business (2017-2022)
    Figure 63. Merck Revenue Growth Rate in Oral Antidiabetic Agents Business (2017-2022)
    Figure 64. Pfizer Revenue Growth Rate in Oral Antidiabetic Agents Business (2017-2022)
    Figure 65. Cipla Revenue Growth Rate in Oral Antidiabetic Agents Business (2017-2022)
    Figure 66. Bottom-up and Top-down Approaches for This Report
    Figure 67. Data Triangulation
    Figure 68. Key Executives Interviewed